David J Lockhart

USPTO Granted Patents = 60 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 6)

Average Co-Inventor Count = 3.1

ph-index = 29

Forward Citations = 3,348(Granted Patents)

Forward Citations (Not Self Cited) = 3,315(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Santa Clara, CA (US) (1996 - 2006)
Mountain View, CA (US) (2000 - 2006)
Del Mar, CA (US) (2001 - 2018)
Emerald Hills, CA (US) (2019 - 2023)
Redwood City, CA (US) (2022 - 2023)

Company Filing History:

Amicus Therapeutics, Inc.

patents

6 out of 39

Ambit Biosciences Corporation

Discoverx Corporation

patents

7. 1 out of 832,680

Other

patents

Years Active: 1996-2023

Loading Chart...

60 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11786610 - Treatment of primary ciliary dyskinesia with synthetic messenger RNA (2023-10-17),

2. 11642421 - Treatment of primary ciliary dyskinesia with synthetic messenger RNA (2023-05-09),

3. 11510997 - Treatment of primary ciliary dyskinesia with synthetic messenger RNA (2022-11-29),

4. 11241422 - Methods for treatment of Fabry disease (2022-02-08),

5. 11033538 - Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones (2021-06-15),

6. 10925866 - Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones (2021-02-23),

7. 10525045 - Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones (2020-01-07),

8. 10406143 - Methods for treatment of fabry disease (2019-09-10),

9. 10383864 - Methods for treatment of Fabry disease (2019-08-20),

10. 9999618 - Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones (2018-06-19),

11. 9987263 - Methods for treatment of Fabry disease (2018-06-05),

12. 9480682 - Methods for treatment of Fabry disease (2016-11-01),

13. 9267165 - Assays and kits for detecting protein binding (2016-02-23),

14. 9056101 - Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones (2015-06-16),

15. 9000011 - Methods for treatment of Fabry disease (2015-04-07),

Title: The Innovative Journey of David J Lockhart

Introduction: David J Lockhart, a talented inventor hailing from Del Mar, CA (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: David J Lockhart's latest patents include cutting-edge advancements in artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, David J Lockhart has worked for renowned tech companies, leading research institutions, and prestigious universities, where he has spearheaded numerous projects that have revolutionized their respective industries.

Collaborations: Throughout his career, David J Lockhart has collaborated with top-tier engineers, scientists, and researchers, fostering a culture of innovation and excellence. His ability to work in multidisciplinary teams has led to the development of groundbreaking technologies that have garnered international acclaim.

Conclusion: David J Lockhart's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his position as a trailblazer in the world of inventions. His remarkable contributions continue to inspire future generations of inventors to dream big and create a better tomorrow.

This text is generated by artificial intelligence and may not be accurate.